NGM Bio to Present at Two Upcoming Investor Conferences

Rhea-AI Summary

NGM Biopharmaceuticals (NGM), a biotechnology company, has announced that CEO David J. Woodhouse, Ph.D., will present a business update at two upcoming investor conferences. The presentations will take place on August 10, 2020, at the BTIG Biotechnology Conference at 11:00 am ET, and on August 13, 2020, at the Canaccord Genuity 40th Annual Growth Conference at 9:00 am ET. A live webcast of these presentations will be available on NGM's website, with a replay accessible for 30 days post-event.

SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will present an overview of the company and provide a business update at two upcoming investor conferences.

Monday, August 10, 2020
Event:  BTIG Biotechnology Conference 2020
Time:  11:00 am ET

Thursday, August 13, 2020
Event: Canaccord Genuity 40^th Annual Growth Conference
Time:  9:00 am ET

A live webcast of these presentations will be available under the Investors and Media section of NGM’s website at https://ir.ngmbio.com/events-presentations. A replay of the presentation will be archived on NGM’s site for 30 days following the event.

About NGM Biopharmaceuticals, Inc.
NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver disease, retinal disease, cancer and metabolic disease. We leverage our biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable us to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. At NGM, we aspire to operate one of the most productive research and development engines in the biopharmaceutical industry, with multiple programs in clinical development. Visit us at www.ngmbio.com for more information.

Investor Contacts: Sylvia Wheeler and Alexandra Santos swheeler@wheelhouselsa.com asantos@wheelhouselsa.com ir@ngmbio.com

Media Contact: Liz Melone media@ngmbio.com

FAQ

What are the dates of NGM's upcoming investor conferences in August 2020?

NGM will present at two investor conferences on August 10 and August 13, 2020.

What time will NGM's CEO present at the BTIG Biotechnology Conference?

David J. Woodhouse, Ph.D., will present at the BTIG Biotechnology Conference at 11:00 am ET.

When is the Canaccord Genuity 40th Annual Growth Conference?

The Canaccord Genuity 40th Annual Growth Conference is scheduled for August 13, 2020, at 9:00 am ET.

How can I access the live webcast of NGM's presentations?

The live webcast can be accessed under the Investors and Media section of NGM's website.

How long will the replay of NGM's presentation be available?

A replay of the presentations will be archived on NGM's site for 30 days following each event.